文献速递膀胱癌与上尿路尿路上皮癌

根治性膀胱切除术五联达标:机器人辅助根治性膀胱切除术后结局报告标准化的提议

Radical cystectomy pentafecta: a proposal for standardisation of outcomes reporting following robot-assisted radical cystectomy.
PubMed 文献 · BJU Int · 2019-07-26

该研究前瞻性分析2010年7月至2017年12月在本机构因膀胱癌接受机器人辅助根治性膀胱切除术加体内尿流改道的277例连续患者,提出可标准化的五联复合终点(切缘阴性、淋巴结产出≥16枚、90天无III-IV级并发症、无尿流改道相关长期后遗症、≤12个月无临床复发),270例可评估患者中五联达标率为53.3%,年龄、尿流改道类型和pN分期为独立预测因素。

要点

  • 五联达标包括切缘阴性、淋巴结≥16枚、90天无III-IV级并发症、无尿流改道后遗症、≤12个月无复发。
  • 270例可评估患者中五联达标率为53.3%。
  • 年龄、尿流改道类型和pN分期为五联达标的独立预测因素。

核心结论

  • 作者提出根治性膀胱切除术五联达标作为可标准化的复合终点,整合围手术期并发症和肿瘤学充分性,可能有助于评估根治性膀胱切除术的质量。
  • 该工具可能有助于评估学习曲线和计算成本效益等,但需在未来研究中外部验证。

研究设计与样本

  • 前瞻性分析2010年7月至2017年12月在本机构因膀胱癌接受机器人辅助根治性膀胱切除术加体内尿流改道的277例连续患者。
  • 277例中270例完成至少12个月随访并纳入分析。

主要发现

  • 平均随访22.3个月,淋巴结产出≥16枚、切缘阴性、90天无III-IV级并发症、无尿流改道相关长期后遗症和≤12个月无临床复发的患者比例分别为93.0%、98.9%、76.7%、81.5%和92.2%。
  • 五联达标率为53.3%。
  • 多因素逻辑回归分析显示年龄(OR 0.95;P=0.002)、尿流改道类型(OR 2.19;P=0.01)和pN分期(OR 0.48;P=0.03)为五联达标的独立预测因素。

关键数值与推荐

  • 五联达标定义为同时满足:切缘阴性、淋巴结产出≥16枚、90天无III-IV级并发症、无尿流改道相关长期后遗症、≤12个月无临床复发。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 该工具需在未来研究中外部验证。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To propose a standardisable composite method for reporting outcomes of radical cystectomy (RC) that incorporates both perioperative morbidity and oncological adequacy. PATIENTS AND METHODS: From July 2010 to December 2017, 277 consecutive patients who underwent robot-assisted RC with intracorporeal urinary diversion (UD) for bladder cancer at our Institution were prospectively analysed. Patients who simultaneously demonstrated negative soft tissue surgical margins (STSMs), ≥16 lymph node (LN) yield, absence of major (grade III-IV) complications at 90 days, absence of UD-related long-term sequelae and absence of clinical recurrence at ≤12 months, were considered as having achieved the RC-pentafecta. A multivariable logistic regression model was assessed to measure predictors for achieving RC-pentafecta. RESULTS AND LIMITATIONS: Since 2010, 270 of 277 patients that had completed at least 12 months of follow-up were included. Over a mean follow-up of 22.3 months, ≥16 LN yield, negative STSMs, absence of major complications at 90 days, and absence of UD-related surgical sequelae and clinical recurrence at ≤12 months were observed in 93.0%, 98.9%, 76.7%, 81.5% and 92.2%, patients, respectively, resulting in a RC-pentafecta rate of 53.3%. Multivariable logistic regression analysis revealed age (odds ratio [OR] 0.95; P = 0.002), type of UD (OR 2.19; P = 0.01) and pN stage (OR 0.48; P = 0.03) as independent predictors for achieving RC-pentafecta. CONCLUSIONS: We present a RC-pentafecta as a standardisable composite endpoint that incorporates perioperative morbidity and oncological adequacy as a potential tool to assess quality of RC. This tool may be useful for assessing the learning curve and calculating cost-effectiveness amongst others but needs to be externally validated in future studies.

来源:BJU Int,查看原文。版权归原作者所有。

引用

  1. Cacciamani GE, Winter M, Medina LG, et al. Radical cystectomy pentafecta: a proposal for standardisation of outcomes reporting following robot-assisted radical cystectomy. BJU Int. 2019. PMID: 31260600. doi:10.1111/bju.14861

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。